MSB 0.64% $1.17 mesoblast limited

Cell Therapy News/Articles, page-17386

  1. 1,738 Posts.
    lightbulb Created with Sketch. 182
    Long Covid study, mitochondria, muscle types etc. From last paragraph in this report on the study:

    “While it is plausible that fatigue is associated with these metabolic abnormalities, other contributing factors, such as persistent inflammation, may also play a role.”

    LINK

    Interested to see MPC investigative study on long covid subjects down the track vis a vis systemic inflammation. One of a number of inflammatory diseases in the queue that may prove treatable with MSB product.
    est. 2 million long covid sufferers UK alone.

    Study in Nature:
    https://www.nature.com/articles/s41467-023-44432-3
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
0.008(0.64%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.15 $1.20 $1.15 $1.686M 1.439M

Buyers (Bids)

No. Vol. Price($)
36 41479 $1.17
 

Sellers (Offers)

Price($) Vol. No.
$1.18 32235 7
View Market Depth
Last trade - 11.45am 16/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.